{"id":"https://openalex.org/W103304032","doi":"https://doi.org/10.1016/s1166-7087(13)70045-9","title":"Choix des nouveaux traitements m\u00e9dicaux dans le cancer de la prostate r\u00e9sistant \u00e0 la castration: marqueurs pr\u00e9dictifs et \u00e9valuation de l\u2019effi cacit\u00e9","display_name":"Choix des nouveaux traitements m\u00e9dicaux dans le cancer de la prostate r\u00e9sistant \u00e0 la castration: marqueurs pr\u00e9dictifs et \u00e9valuation de l\u2019effi cacit\u00e9","alternate_titles":[],"publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W103304032","doi":"https://doi.org/10.1016/s1166-7087(13)70045-9","mag":"103304032","pmid":"https://pubmed.ncbi.nlm.nih.gov/24314738"},"language":"fr","primary_location":{"id":"doi:10.1016/s1166-7087(13)70045-9","doi":"https://doi.org/10.1016/s1166-7087(13)70045-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1166-7087(13)70045-9","pdf_url":null,"source":{"id":"https://openalex.org/S73435037","display_name":"The French Journal of Urology","issn_l":"1166-7087","issn":["1166-7087","2405-5131","2950-3930"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progr\u00e8s en Urologie","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W103304032"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028972854","display_name":"V. Basset","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"V. Basset","raw_affiliation_strings":["Service d'urologie, CHU Saint-Louis, 1 av Claude-Vellefaux, 75010 Paris, France. Electronic address: victor_basset@yahoo.fr","Service d'urologie, CHU Saint-Louis, 1 av Claude-Vellefaux, 75010 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'urologie, CHU Saint-Louis, 1 av Claude-Vellefaux, 75010 Paris, France. Electronic address: victor_basset@yahoo.fr","institution_ids":["https://openalex.org/I4210144610"]},{"raw_affiliation_string":"Service d'urologie, CHU Saint-Louis, 1 av Claude-Vellefaux, 75010 Paris, France","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016153087","display_name":"Vincent Flamand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]},{"id":"https://openalex.org/I59807433","display_name":"Universit\u00e9 Lille Nord de France","ror":"https://ror.org/03btvgn05","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970","https://openalex.org/I59807433"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Flamand","raw_affiliation_strings":["Service d\u2019urologie, universit\u00e9 de Lille Nord-de-France, h\u00f4pital Claude-Huriez, CHU de Lille, 2 rue Michel-Polonovski 59000 Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d\u2019urologie, universit\u00e9 de Lille Nord-de-France, h\u00f4pital Claude-Huriez, CHU de Lille, 2 rue Michel-Polonovski 59000 Lille, France","institution_ids":["https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4210155195","https://openalex.org/I59807433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080354002","display_name":"S\u00e9bastien Crouzet","orcid":"https://orcid.org/0000-0001-5812-6771","observed_orcids":["https://orcid.org/0000-0001-5812-6771"]},"institutions":[{"id":"https://openalex.org/I4210123600","display_name":"H\u00f4pital Edouard Herriot","ror":"https://ror.org/02qt1p572","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210123600"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Crouzet","raw_affiliation_strings":["Service d\u2019urologie, h\u00f4pital Edouard-Herriot, 5 place d\u2019Arsonval, 69437 Lyon Cedex 03, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d\u2019urologie, h\u00f4pital Edouard-Herriot, 5 place d\u2019Arsonval, 69437 Lyon Cedex 03, France","institution_ids":["https://openalex.org/I4210123600"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088072625","display_name":"Guillaume Ploussard","orcid":"https://orcid.org/0000-0002-6004-2152","observed_orcids":["https://orcid.org/0000-0002-6004-2152"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Ploussard","raw_affiliation_strings":["Inserm U955Eq7, Paris-Est Cr\u00e9teil, France","Service d\u2019urologie, CHU Saint-Louis, 1 av Claude-Vellefaux, 75010 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm U955Eq7, Paris-Est Cr\u00e9teil, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I197681013"]},{"raw_affiliation_string":"Service d\u2019urologie, CHU Saint-Louis, 1 av Claude-Vellefaux, 75010 Paris, France","institution_ids":["https://openalex.org/I4210144610"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5028972854"],"corresponding_institution_ids":["https://openalex.org/I4210144610"],"apc_list":{"value":1910,"currency":"USD","value_usd":1910},"apc_paid":null,"fwci":0.054,"has_fulltext":false,"cited_by_count":3,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.04198966,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"23","issue":null,"first_page":"S44","last_page":"S48"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9580000042915344},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7979999780654907},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.625},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9520000219345093},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9490000009536743},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.7730000019073486},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5690000057220459},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.5049999952316284},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.7350000143051147},{"id":"https://openalex.org/keywords/gleason-score","display_name":"Gleason score","score":0.8349999785423279},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.6779999732971191},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.7020000219345093},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.831113338470459},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7815306186676025},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6866881251335144},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5712887644767761},{"id":"https://openalex.org/C2776421732","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone","level":5,"score":0.5433599948883057},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5144720077514648},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4863913357257843},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.43611210584640503},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41558289527893066},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.36078548431396484},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3396490216255188},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32067859172821045},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.1938115358352661}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000736","descriptor_name":"Androstenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000737","descriptor_name":"Androstenols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017430","descriptor_name":"Prostate-Specific Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/s1166-7087(13)70045-9","doi":"https://doi.org/10.1016/s1166-7087(13)70045-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1166-7087(13)70045-9","pdf_url":null,"source":{"id":"https://openalex.org/S73435037","display_name":"The French Journal of Urology","issn_l":"1166-7087","issn":["1166-7087","2405-5131","2950-3930"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progr\u00e8s en Urologie","raw_type":"journal-article"},{"id":"pmid:24314738","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24314738","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie","raw_type":"Journal Article"},{"id":"mag:3022125300","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/24314738","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Progr\u00e8s en Urologie","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1607353937","https://openalex.org/W1889335195","https://openalex.org/W2016006304","https://openalex.org/W2018083632","https://openalex.org/W2038932619","https://openalex.org/W2044287047","https://openalex.org/W2059381583","https://openalex.org/W2068744546","https://openalex.org/W2080134152","https://openalex.org/W2080439368","https://openalex.org/W2080798348","https://openalex.org/W2088318211","https://openalex.org/W2110534364","https://openalex.org/W2112564453","https://openalex.org/W2114281628","https://openalex.org/W2116458141","https://openalex.org/W2120292596","https://openalex.org/W2123526148","https://openalex.org/W2131456094","https://openalex.org/W2132850027","https://openalex.org/W2142466432","https://openalex.org/W2148643283","https://openalex.org/W2158176392","https://openalex.org/W2161193168","https://openalex.org/W2169737508","https://openalex.org/W2244473630","https://openalex.org/W2589802334","https://openalex.org/W2601357387","https://openalex.org/W2886226330","https://openalex.org/W3003729825"],"related_works":["https://openalex.org/W2094706429","https://openalex.org/W2080798348","https://openalex.org/W2985005545","https://openalex.org/W2167582333","https://openalex.org/W2766734872","https://openalex.org/W122619847","https://openalex.org/W2614563631","https://openalex.org/W2125068539","https://openalex.org/W2911305882","https://openalex.org/W2416590103"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W103304032","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
